Vaccine advisers to the U.S. Centers for Disease Control and Prevention (CDC) voted unanimously Thursday to recommend the Pfizer-BioNTech and Moderna COVID-19 vaccines be preferred over the Johnson & Johnson vaccine due to very rare but dangerous blood clot risk.